Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Eyeing big returns, drugmakers ready new hepatitis-C drug launches
Medical Marketing and Media
Wed, 07/29/15 - 09:46 pm
Tags:
hepatitis C, Merck, grazoprevir/elbasvir, Gilead Sciences, Harvoni, Sovaldi
Gilead beats Street 2Q forecasts on surge in sales, profit
Yahoo/AP
Wed, 07/29/15 - 10:14 am
Tags:
Gilead Sciences, earnings
Are These 2 Big Pharmas Really Buyout Candidates?
Motley Fool
Tue, 07/28/15 - 10:05 am
Tags:
M&A, Bristol-Myers Squibb, AstraZeneca, Pfizer, Gilead Sciences
Gilead Sciences: Sure, It’s Hep-C But It’s Not Just Hep-C
Barron's
Tue, 07/28/15 - 12:38 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Bristol-Myers snags a hep C approval to piggyback on Gilead's blockbuster
Fierce Biotech
Mon, 07/27/15 - 01:28 pm
Tags:
Bristol-Myers Squibb, Gilead Sciences, hepatitis C, Daklinza, Sovaldi
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
24/7 Wall St
Sun, 07/26/15 - 12:25 pm
Tags:
earnings, Merck, Pfizer, Amgen, Gilead Sciences
What to Expect From Gilead Sciences Inc.'s Q2 Results
Motley Fool
Fri, 07/24/15 - 09:12 am
Tags:
Gilead Sciences, earnings
Drugmakers like Gilead, Mylan and Novo--not Big Pharma--are job creators
Fierce Pharma
Wed, 07/22/15 - 09:40 pm
Tags:
Big Pharma, Gilead Sciences, Mylan Labs, Novo Nordisk, Merck, Bayer
Why Gilead Will Beat Earnings Forecasts
Barron's
Mon, 07/20/15 - 10:51 pm
Tags:
Gilead Sciences, earnings
Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers
WSJ Pharmalot
Thu, 07/16/15 - 04:50 pm
Tags:
hepatitis C, Gilead Sciences, patients, Harvoni, Sovaldi
What Will Gilead Buy Next? 4 Possible Targets
Investors.com
Wed, 07/15/15 - 06:30 pm
Tags:
Gilead Sciences, M&A, Incyte, Vertex Pharmaceuticals, Bristol-Myers Squibb, Achillion
5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Tags:
Amicus Therapeutics, Galafold, Receptos, ozanimod, GS-5816, Gilead Sciences, ACH-3102, Achillion, Ophthotech, Fovista
Gilead Pills Priced at $1,000 a Day Are Found Cost-Effective
Bloomberg
Mon, 07/13/15 - 10:01 am
Tags:
Gilead Sciences, drug pricing, hepatitis C, Harvoni, Sovaldi
Fast-paced changes in drugs for hepatitis C seen as harbinger of rising US health care costs
Yahoo/AP
Sat, 07/11/15 - 10:20 am
Tags:
drug pricing, hepatitis C, Harvoni, Sovaldi, AbbVie, Gilead Sciences, Viekira Pak
Gilead Sciences: Does Anyone Care About Hep-C Anymore?
Barron's
Fri, 07/10/15 - 01:43 pm
Tags:
Gilead Sciences, hepatitis C, AbbVie, Harvoni, Sovaldi, Viekira Pak
Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
BioPharma Dive
Tue, 07/7/15 - 10:51 am
Tags:
Sanofi, Gilead Sciences, Japan, Lantus, Harvoni, diabetes, hepatitis C
Gilead Sciences Spent $125 Million to Get This Drug on the Market 4 Months Early
Motley Fool
Mon, 07/6/15 - 04:28 pm
Tags:
Gilead Sciences, R/F/TAF, HIV
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF)
Yahoo
Wed, 07/1/15 - 10:51 pm
Tags:
Gilead Sciences, HIV, R/F/TAF, FDA
FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data
WSJ Pharmalot
Mon, 06/29/15 - 11:37 am
Tags:
FDA, Gilead Sciences, hepatitis C, clinical trial data
Acquisitions May Fuel Gilead Sciences' Winning Ways
Investors.com
Sat, 06/27/15 - 12:05 pm
Tags:
M&A, Gilead Sciences, Vertex Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.